| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.49 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.45 | 0.009 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |